PRRT2 and head and neck squamous cell carcinoma: CHE interacted with PKC and significantly decreased cisplatin IC50 values in six cell lines derived from HNSCC in combination with cisplatin (IC50 = 0.4–5.8 μg/ml), which also increased the cisplatin sensitivity of the HNSCC cell lines (Hoffmann et al., 2002).